Montelukast Prescribing at BURLINGTON PRIMARY CARE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,755
Total Quantity
44.3K
NHS Cost
£2.0K
vs National Avg
+156.3%
BURLINGTON PRIMARY CARE prescribed 1,755 items of Montelukast over the last 12 months at a cost of £2,029 to the NHS. This is 156.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
152
Jul 2026
147
Jul 2026
160
Jul 2026
151
Jul 2026
139
Jul 2026
141
Jul 2026
150
Jul 2026
163
Jul 2026
147
Jul 2026
135
Jul 2026
136
Jul 2026
134
Prescribing Details
| Total Items | 1,755 |
|---|---|
| Total Quantity | 44,283 |
| Total NHS Cost | £2,029 |
| Presentations | 4 different forms |
| vs National Average | +156.3% |
Montelukast Prescribing Comparison
| This practice | 1,755 items |
|---|---|
| National average per practice | 685 items |
| Difference | +156.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.